Skip to main content

Table 3 Patients’ characteristics

From: Long-term cost-utility analysis of remote monitoring of older patients with pacemakers: the PONIENTE study

  All RM group (n = 21) CM group (n = 34) p-value
Age (mean) ± SD 81.00 ± 6.47 81.14 ± 7.30 80.91 ± 6.01 0.690
Women (%) 17 (30.91) 8 (38.10) 9 (26.47) 0.365
Attrition (a) 28 (34.14) 9 (27.58) 18 (33.96) 0.481
Pacing indication (%)(b)
 Sinus node disease 11 (20.00) 3 (14.29) 8 (23.53) 0.493
 Atrioventricular block 39 (70.91) 15 (71.43) 24 (70.59)
 Others 5 (9.09) 3 (14.29) 2 (5.88)
Disease manifestations (%)(b)
 Syncope 33 (60.00) 13 (61.90) 20 (58.82) 0.681
 Dizziness 16 (29.09) 7 (33.33) 9 (26.47)
 Dyspnoea 3 (5.45) 0 (0) 3 (8.82)
 Angina 3 (5.45) 1 (4.76) 2 (5.88)
  1. CM Conventional monitoring; RM Remote monitoring
  2. (a) Concerned to the total initial patients (83)
  3. (b) Indications and manifestations before the PM implant over the remaining sample at the end of the study